Why I invited investors into my lab
In December 2021, ATP, a leader in life sciences venture capital, announced the launch of Adendra Therapeutics Ltd, a spin-out of immunology research by Crick Principal Group Leader Caetano Reis e Sousa and his team. One year on, Caetano explains why working with ATP on early stage discovery research in his lab has been key to the early success of Adendra.
Published: 17 January 2023